Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Celebrex for Pain Relief After Oral Surgery [Phase 2]

View source ↗

Summary

Phase 2 study update evaluating Celebrex (celecoxib) for pain relief after oral surgery; the trial conducted by NIDCR is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELEBREX (Celecoxib)

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Facial Pain | Phase 2 | Status: COMPLETED